Genetic variants in combination with early partial improvement as a clinical utility predictor of treatment outcome in major depressive disorder: the result of two pooled RCTs.
Translational psychiatry 2015 5 e513.
Kato M, Serretti A, Nonen S, Takekita Y, Wakeno M, Azuma J, Kinoshita
Effect of basic fibroblast growth factor (FGF2) gene polymorphisms on SSRIs treatment response and side effects.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2009 Jul .
Kato M, Okugawa G, Wakeno M, Takekita Y, Nonen S, Tetsuo S, Nishida K, Azuma J, Kinoshita T, Serretti A